BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 28409272)

  • 21. Taar1-mediated modulation of presynaptic dopaminergic neurotransmission: role of D2 dopamine autoreceptors.
    Leo D; Mus L; Espinoza S; Hoener MC; Sotnikova TD; Gainetdinov RR
    Neuropharmacology; 2014 Jun; 81():283-91. PubMed ID: 24565640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trace amine-associated receptor 1 (TAAR1) agonism as a new treatment strategy for schizophrenia and related disorders.
    Halff EF; Rutigliano G; Garcia-Hidalgo A; Howes OD
    Trends Neurosci; 2023 Jan; 46(1):60-74. PubMed ID: 36369028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of Pofut1 and activated Notch1 may be associated with poor prognosis in breast cancer.
    Wan G; Tian L; Yu Y; Li F; Wang X; Li C; Deng S; Yu X; Cai X; Zuo Z; Cao F
    Biochem Biophys Res Commun; 2017 Sep; 491(1):104-111. PubMed ID: 28709865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of SATB1 and HER2 in breast cancer and the correlations with clinicopathologic characteristics.
    Liu X; Zheng Y; Qiao C; Qv F; Wang J; Ding B; Sun Y; Wang Y
    Diagn Pathol; 2015 May; 10():50. PubMed ID: 25956130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biogenic amines activate blood leukocytes via trace amine-associated receptors TAAR1 and TAAR2.
    Babusyte A; Kotthoff M; Fiedler J; Krautwurst D
    J Leukoc Biol; 2013 Mar; 93(3):387-94. PubMed ID: 23315425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methamphetamine induces trace amine-associated receptor 1 (TAAR1) expression in human T lymphocytes: role in immunomodulation.
    Sriram U; Cenna JM; Haldar B; Fernandes NC; Razmpour R; Fan S; Ramirez SH; Potula R
    J Leukoc Biol; 2016 Jan; 99(1):213-23. PubMed ID: 26302754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploring prognostic factors for HER2-positive metastatic breast cancer: a retrospective cohort study in a major Swiss hospital.
    Bringolf L; Pestalozzi B; Fink D; Dedes K
    Swiss Med Wkly; 2016; 146():w14393. PubMed ID: 28102883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trace amine-associated receptor gene polymorphism increases drug craving in individuals with methamphetamine dependence.
    Loftis JM; Lasarev M; Shi X; Lapidus J; Janowsky A; Hoffman WF; Huckans M
    PLoS One; 2019; 14(10):e0220270. PubMed ID: 31600226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aneuploidy identifies subsets of patients with poor clinical outcome in grade 1 and grade 2 breast cancer.
    Pinto AE; Pereira T; Silva GL; André S
    Breast; 2015 Aug; 24(4):449-55. PubMed ID: 25920680
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Trace Amine-Associated Receptor 1 Agonist 3-Iodothyronamine Induces Biased Signaling at the Serotonin 1b Receptor.
    Bräunig J; Dinter J; Höfig CS; Paisdzior S; Szczepek M; Scheerer P; Rosowski M; Mittag J; Kleinau G; Biebermann H
    Front Pharmacol; 2018; 9():222. PubMed ID: 29593543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of monoamine transporters by common biogenic amines via trace amine-associated receptor 1 and monoamine autoreceptors in human embryonic kidney 293 cells and brain synaptosomes.
    Xie Z; Westmoreland SV; Miller GM
    J Pharmacol Exp Ther; 2008 May; 325(2):629-40. PubMed ID: 18310473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trace Amine-Associated Receptor 1 Localization at the Apical Plasma Membrane Domain of Fisher Rat Thyroid Epithelial Cells Is Confined to Cilia.
    Szumska J; Qatato M; Rehders M; Führer D; Biebermann H; Grandy DK; Köhrle J; Brix K
    Eur Thyroid J; 2015 Sep; 4(Suppl 1):30-41. PubMed ID: 26601071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trace Amines and the Trace Amine-Associated Receptor 1: Pharmacology, Neurochemistry, and Clinical Implications.
    Pei Y; Asif-Malik A; Canales JJ
    Front Neurosci; 2016; 10():148. PubMed ID: 27092049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trace Amine-Associated Receptor 1 Trafficking to Cilia of Thyroid Epithelial Cells.
    Qatato M; Venugopalan V; Al-Hashimi A; Rehders M; Valentine AD; Hein Z; Dallto U; Springer S; Brix K
    Cells; 2021 Jun; 10(6):. PubMed ID: 34208608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enzyme-linked immunoabsorbent assay-detected p53 protein accumulation: a prognostic factor in a large breast cancer cohort.
    Levesque MA; Yu H; Clark GM; Diamandis EP
    J Clin Oncol; 1998 Aug; 16(8):2641-50. PubMed ID: 9704714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Moderate level of HER2 expression and its prognostic significance in breast cancer with intermediate grade.
    Ignatov T; Eggemann H; Burger E; Fettke F; Costa SD; Ignatov A
    Breast Cancer Res Treat; 2015 Jun; 151(2):357-64. PubMed ID: 25926338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic significance of interferon regulating factor 4 (IRF4) in node-negative breast cancer.
    Heimes AS; Madjar K; Edlund K; Battista MJ; Almstedt K; Gebhard S; Foersch S; Rahnenführer J; Brenner W; Hasenburg A; Hengstler JG; Schmidt M
    J Cancer Res Clin Oncol; 2017 Jul; 143(7):1123-1131. PubMed ID: 28251349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Minimal Age-Related Alterations in Behavioral and Hematological Parameters in Trace Amine-Associated Receptor 1 (TAAR1) Knockout Mice.
    Zhukov IS; Kubarskaya LG; Tissen IY; Kozlova AA; Dagayev SG; Kashuro VA; Vlasova OL; Sinitca EL; Karpova IV; Gainetdinov RR
    Cell Mol Neurobiol; 2020 Mar; 40(2):273-282. PubMed ID: 31399838
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Receptor activator for nuclear factor κ B expression predicts poor prognosis in breast cancer patients with bone metastasis but not in patients with visceral metastasis.
    Zhang L; Teng Y; Zhang Y; Liu J; Xu L; Qu J; Hou K; Yang X; Liu Y; Qu X
    J Clin Pathol; 2012 Jan; 65(1):36-40. PubMed ID: 22049226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EP3 (prostaglandin E2 receptor 3) expression is a prognostic factor for progression-free and overall survival in sporadic breast cancer.
    Semmlinger A; von Schoenfeldt V; Wolf V; Meuter A; Kolben TM; Kolben T; Zeder-Goess C; Weis F; Gallwas J; Wuerstlein R; Hermelink K; Schmoeckel E; Harbeck N; Mayr D; Mahner S; Jeschke U; Ditsch N
    BMC Cancer; 2018 Apr; 18(1):431. PubMed ID: 29661238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.